Benralizumab has been used to treat an acute asthma attack in a patient with a serious adverse reaction to steroids, respiratory physicians in the UK report. The anti-IL5ra monoclonal antibody is licensed in the UK for the prevention of asthma attacks only. The team of doctors from the Nuffield Department of Clinical Medicine, Oxford, detailed ...
Benralizumab used to treat near-fatal asthma
By Nicola Garrett
12 Feb 2020